Developer docs
API playgroundTry for free, no card

Search company profiles

BOTALYS

Full company profile

uuid0002dbf

Namestring
BOTALYS
Legal namestring
BOTALYS S.A.
Websiteurl
botalys.com
Company typeenum
Private
Founded yearint
2011
Descriptiontext

BOTALYS is a Belgian biotech company founded in 2011 that develops and supplies premium botanical ingredients to the nutraceutical and cosmeceutical industries. Its core technology is Biomimetic Indoor Farming — a proprietary controlled-environment agriculture system that replicates the environmental conditions of wild botanical habitats (light, atmosphere, thermal, hygroscopic, substrate, and ecosystem variables) inside a 2,000 sqm vertical farm in Ghislenghien, Belgium, with a current production capacity of 50–60 tonnes per year. This enables consistent, standardized bioactive profiles equivalent to wild-harvested specimens while eliminating contamination, adulteration, and sustainability issues associated with wild sourcing.

The company's commercial portfolio spans core ingredients (Korean Red Ginseng with 10% rare ginsenosides, Fjord Rhodiola with a molecular profile equivalent to a 15-year-old wild Nordic specimen), processed variants (Red and Black Ginseng), and emerging cosmetic actives (Sichuan Red Sage and others). BOTALYS generates revenue through B2B ingredient sales on a quote-based, multi-year contract model to nutraceutical manufacturers (Throne, Terry Naturally, Ora, Therascience, Nutri-Logics, Laboratoire Optim) and cosmeceutical brands (L'Oréal, Seppic), with strategic co-development partnerships creating exclusive ingredient IP for major customers including Haleon (consumer healthcare) and L'Oréal/Brightseed (cosmetics with AI-powered discovery).

BOTALYS operates with 11–50 employees across its Belgian HQ and US subsidiary (Austin, TX, opened 2023), supported by ~$20M+ in cumulative funding from investors including ALIAD (Air Liquide's VC arm), S.R.I.W., Vives Louvain Technology Fund, WapInvest, Teseo Capital, and Horizon 2020. The company has built a vertically integrated seed-to-ingredient pipeline with EU-quality certifications (ISO 9001, EFfCI GMP, FSSC 22000, GLOBALG.A.P., Halal, Kosher) and clinically validated efficacy claims across its lead ingredients.

Short descriptiontext

BOTALYS is a Belgian biotech that develops premium, standardized botanical ingredients for nutraceutical and cosmeceutical manufacturers using proprietary Biomimetic Indoor Farming technology, replicating wild-growing conditions in vertical farms.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersGhislenghien, Belgium
HQ citystring
Ghislenghien
HQ countrystring
Belgium
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
botanical ingredients, nutraceutical ingredients, cosmeceutical actives, biomimetic indoor farming, medicinal plant extracts
Industry3 codes
PRIMARYAFAJAKAD
Botanical & Herbal Extracts (Adaptogens, Polyphenols, Essential Oils, Standardized Extracts)
Agriculture & Food Production/Food Ingredients & Additives/Nutraceutical & Functional Ingredients (Vitamins, Minerals, Omega-3s, Botanicals)
SECONDARYAFAGAHAC
Greenhouse Herb & Microgreens Production (Culinary Herbs, Microgreens)
Agriculture & Food Production/Crop Farming/Greenhouse, Nursery & Floriculture Production (Protected Crops, Ornamentals, Seedlings)
SECONDARYAFAGAGAE
Medicinal Plant Farming (Botanical/Pharmaceutical Crops)
Agriculture & Food Production/Crop Farming/Specialty & Industrial Crop Farming (Tobacco, Hops, Spices, Medicinal/Aromatic Plants)
NAICS code1 code
  • Medicinal and Botanical Manufacturing325411
SIC code1 code
  • Medicinal Chemicals & Botanical Products2833
Product category
Nutraceutical & Cosmeceutical Botanical Ingredients
Social media profiles3 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Premium Botanical Ingredients — B2B Ingredient Sales
TypeOne Time License
Description

BOTALYS develops and sells ultra-pure, standardized botanical ingredient powders and extracts (Korean Red Ginseng, Fjord Rhodiola, Red Sage, and others in development) to nutraceutical and cosmeceutical manufacturers. Ingredients are supplied with certifications including DNA identification, vegan, halal, and kosher, along with comprehensive quality analyses. The company operates a co-development model where it partners with clients to develop exclusive botanical ingredients.

botalys.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Operations, Personnel, Technology or R&D, Marketing or Sales, Supply Chain, Infrastructure
Pricing details1 tier
1B2B ingredient sales — no public pricing; quote-based
ModelOtherBilling cadenceMulti-year contract
Notes

Sample pack and technical consultation available via website contact form. Pricing likely varies by ingredient, volume, and exclusivity terms.

botalys.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

BOTALYS develops, cultivates, and supplies ultra-pure, standardized premium botanical ingredient powders and extracts — including Korean Ginseng (Panax ginseng), Fjord Rhodiola (Rhodiola rosea), Red & Black Ginseng variants, and an emerging cosmetic active ingredients portfolio — for nutraceutical and cosmeceutical manufacturers. Production relies on its proprietary Biomimetic Indoor Farming vertical-farm technology, which replicates wild botanical habitats to deliver batch-to-batch standardized bioactive profiles equivalent to wild-harvested specimens, with full traceability from seed to ingredient and certifications covering DNA identification, vegan, halal, and kosher compliance. The company also operates a co-development platform enabling the development of exclusive, proprietary botanical ingredients with industry partners from feasibility through industrial scale-up.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 7 values shown
  • 74% memory capacity recovery in aged mice supplemented with BOTALYS Red Ginseng vs. young mice in Y-maze test (50 mg/kg/day, 8 days)
+6 more records
Product overview1 text field

BOTALYS is a Belgian supplier and developer of premium botanical ingredients for the nutraceutical and cosmeceutical industries. The company operates a proprietary Biomimetic Indoor Farming platform that enables the precise control of plant growth conditions to produce consistent, high-quality botanicals equivalent to wild-harvested plants. Core products include Korean Ginseng (Panax ginseng) for mental stamina and Fjord Rhodiola (Rhodiola rosea) for adaptogenic benefits, alongside processed variants (Red & Black Ginseng). The company also offers a New Plant Development Platform for co-development partnerships to create exclusive botanical ingredients, with emerging cosmetic active ingredients in development. All ingredients are produced in Belgium using vertically integrated seed-to-ingredient processes.

Product and service5 records
1Korean Ginseng (Panax ginseng)
CategoryNutraceutical Botanical Ingredient
Description

Premium botanical ingredient developed using BOTALYS' Biomimetic Indoor Farming technology, specifically formulated to promote mental stamina with clinically demonstrated efficacy against factors of mental load including focus, stress, and memory. Contains 10% rare ginsenosides (Rg3, Rg5, Rk1). For nutraceutical manufacturers.

2Fjord Rhodiola (Rhodiola rosea)
CategoryNutraceutical Botanical Ingredient
Description

Unique Nordic Rhodiola rosea cultivar developed over 4 years of R&D, producing a potent European Rhodiola with a molecular profile equivalent to a 15-year-old wild Nordic specimen. Known for boosting physical and mental stamina. For nutraceutical and adaptogenic supplement manufacturers.

3Red & Black Ginseng
CategoryNutraceutical Botanical Ingredient (Processed Variant)
Description

Processed ginseng products derived from BOTALYS' Korean Ginseng, including steam-cooked red ginseng and multi-cycle black ginseng, with enhanced bioactive ginsenoside profiles for various health applications. For nutraceutical manufacturers.

4Cosmetic Active Ingredients
CategoryCosmeceutical Active Ingredient
Description

Dedicated portfolio of botanical ingredients being developed for cosmetic applications, targeting the cosmeceutical market. Includes Sichuan Red Sage (Salvia miltiorrhiza) and other actives in development for skincare and personal care formulations. For cosmetic and personal care manufacturers.

5New Plant Development Platform
CategoryCo-Development Platform / Service
Description

Co-development platform enabling the development of rare, high-performance botanical ingredients from feasibility to industrial scale through exclusive partnerships with industry leaders. Covers technical specifications, non-technical validation, rare plant sourcing, vitroplant production, cultivar selection, process optimization, and industrial scale-up. For enterprise partners in nutraceuticals, cosmeceuticals, and consumer health.

Scale indicator8 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-10-16
Description

Strategic collaboration announced October 16, 2025 to develop innovative botanical ingredients using BOTALYS' indoor cultivation platform and Haleon's consumer healthcare portfolio. Partnership focuses on scientific and regulatory standards, sustainability, and advancing plant-based health solutions through multiple research and development phases.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-01-01
Description

Partnership launched in 2024 with L'Oréal and Brightseed (AI-powered plant compound exploration company) as part of L'Oréal's Green Sciences incubator and R&I Exploration Trailblazer program. The collaboration leverages AI to explore plant compounds for cosmetic applications using BOTALYS' botanical platform.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2023-01-01
Description

Co-development and distribution partnership launched in 2023. Seppic and BOTALYS signed a partnership for co-development and distribution of botanical ingredients, combining Seppic's formulation expertise and distribution network with BOTALYS' cultivation technology.

Recent move9 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Italian-headquartered developer and manufacturer of standardized botanical extracts for the pharmaceutical, nutraceutical, and cosmeceutical industries. Directly comparable to BOTALYS in target customers (premium B2B ingredient buyers), botanical standardization expertise, and clinical efficacy focus.

TypeDirect peer
Description

US-based manufacturer of standardized botanical extracts and nutraceutical ingredients with a broad branded SKU portfolio. Highly comparable to BOTALYS as a science-driven, vertically integrated botanical ingredient supplier serving nutraceutical and personal care brands globally.

TypeDirect peer
Description

Spanish producer of standardized botanical and fruit extracts for nutraceutical and pharmaceutical applications. Comparable to BOTALYS in standardized extract positioning, B2B sales to health brands, and emphasis on clinical-grade quality documentation.

4Naturex (Givaudan)
TypeBroad incumbent
Description

Naturex, now part of Givaudan, is one of the largest global suppliers of plant-based extracts for food, nutraceutical, and cosmetic applications. A broad incumbent offering overlapping standardized botanical capabilities at much greater scale than BOTALYS, including conventional and some cultivated sourcing.

TypeDirect peer
Description

Supplier of scientifically validated, naturally sourced ingredients for dietary supplements and functional foods. Comparable to BOTALYS in premium, evidence-led botanical ingredient positioning for global nutraceutical brands.

TypeBroad incumbent
Description

Global ingredient manufacturer serving human/animal nutrition, food, and personal care with botanical extracts and specialty ingredients. Broader portfolio than BOTALYS but overlaps in standardized plant-based actives for nutraceutical and cosmetic applications.

TypeEmerging player
Description

Spanish specialist in premium, sustainably sourced botanical extracts for nutraceutical and functional food markets. Comparable to BOTALYS in B2B premium botanical positioning, clinical substantiation, and focus on unique, differentiated plant actives.

TypeDirect peer
Description

Swiss-based manufacturer of high-purity botanical extracts and active pharmaceutical ingredients from medicinal plants. Comparable to BOTALYS in vertically integrated, GMP-grade botanical manufacturing for pharma-adjacent and nutraceutical buyers.

TypeBroad incumbent
Description

Global taste and nutrition company supplying functional ingredients, botanical extracts, and nutraceutical solutions to food, beverage, and supplement manufacturers. Broader incumbent with significant overlap in botanical ingredient supply to large CPG customers.

TypeEmerging player
Description

French developer of clinically supported, plant-based active ingredients for the nutraceutical and dermo-cosmetic markets. Closely comparable to BOTALYS in premium B2B botanical actives, clinical efficacy positioning, and focus on cosmeceutical channels.

Market position
Strengths1 record

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers9 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance7 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds11 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors7 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

BOTALYS

Nutraceutical & Cosmeceutical Botanical Ingredientsbotalys.com

BOTALYS is a Belgian biotech that develops premium, standardized botanical ingredients for nutraceutical and cosmeceutical manufacturers using proprietary Biomimetic Indoor Farming technology, replicating wild-growing conditions in vertical farms.

What BOTALYS does

BOTALYS is a Belgian biotech company founded in 2011 that develops and supplies premium botanical ingredients to the nutraceutical and cosmeceutical industries. Its core technology is Biomimetic Indoor Farming — a proprietary controlled-environment agriculture system that replicates the environmental conditions of wild botanical habitats (light, atmosphere, thermal, hygroscopic, substrate, and ecosystem variables) inside a 2,000 sqm vertical farm in Ghislenghien, Belgium, with a current production capacity of 50–60 tonnes per year. This enables consistent, standardized bioactive profiles equivalent to wild-harvested specimens while eliminating contamination, adulteration, and sustainability issues associated with wild sourcing.

The company's commercial portfolio spans core ingredients (Korean Red Ginseng with 10% rare ginsenosides, Fjord Rhodiola with a molecular profile equivalent to a 15-year-old wild Nordic specimen), processed variants (Red and Black Ginseng), and emerging cosmetic actives (Sichuan Red Sage and others). BOTALYS generates revenue through B2B ingredient sales on a quote-based, multi-year contract model to nutraceutical manufacturers (Throne, Terry Naturally, Ora, Therascience, Nutri-Logics, Laboratoire Optim) and cosmeceutical brands (L'Oréal, Seppic), with strategic co-development partnerships creating exclusive ingredient IP for major customers including Haleon (consumer healthcare) and L'Oréal/Brightseed (cosmetics with AI-powered discovery).

BOTALYS operates with 11–50 employees across its Belgian HQ and US subsidiary (Austin, TX, opened 2023), supported by ~$20M+ in cumulative funding from investors including ALIAD (Air Liquide's VC arm), S.R.I.W., Vives Louvain Technology Fund, WapInvest, Teseo Capital, and Horizon 2020. The company has built a vertically integrated seed-to-ingredient pipeline with EU-quality certifications (ISO 9001, EFfCI GMP, FSSC 22000, GLOBALG.A.P., Halal, Kosher) and clinically validated efficacy claims across its lead ingredients.

BOTALYS firmographics

Firmographics
Name
BOTALYS
Legal name
BOTALYS S.A.
Website
https://botalys.com
Company type
Private
Founded year
2011
Operating status
Operating
Headcount range
11–50 employees
Short description
BOTALYS is a Belgian biotech that develops premium, standardized botanical ingredients for nutraceutical and cosmeceutical manufacturers using proprietary Biomimetic Indoor Farming technology, replicating wild-growing conditions in vertical farms.
Ownership category
akta.pro rank

BOTALYS industry classification

Industry
Product category
Nutraceutical & Cosmeceutical Botanical Ingredients
NAICS
Medicinal and Botanical Manufacturing (325411)
SIC
Medicinal Chemicals & Botanical Products (2833)
akta.pro industry
PRIMARYAFAJAKAD
Botanical & Herbal Extracts (Adaptogens, Polyphenols, Essential Oils, Standardized Extracts)
Agriculture & Food Production/Food Ingredients & Additives/Nutraceutical & Functional Ingredients (Vitamins, Minerals, Omega-3s, Botanicals)
SECONDARYAFAGAHAC
Greenhouse Herb & Microgreens Production (Culinary Herbs, Microgreens)
Agriculture & Food Production/Crop Farming/Greenhouse, Nursery & Floriculture Production (Protected Crops, Ornamentals, Seedlings)
SECONDARYAFAGAGAE
Medicinal Plant Farming (Botanical/Pharmaceutical Crops)
Agriculture & Food Production/Crop Farming/Specialty & Industrial Crop Farming (Tobacco, Hops, Spices, Medicinal/Aromatic Plants)

Keywords

  • Botanical ingredients
  • Nutraceutical ingredients
  • Cosmeceutical actives
  • Biomimetic indoor farming
  • Medicinal plant extracts

Where BOTALYS is headquartered

Location

Headquarters

HQ city
Ghislenghien
HQ country
Belgium
HQ region
Europe

Offices2 records

Markets served

BOTALYS business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Operations, Personnel, Technology or R&D, Marketing or Sales, Supply Chain, Infrastructure

Revenue model

  1. Premium Botanical Ingredients — B2B Ingredient Sales: BOTALYS develops and sells ultra-pure, standardized botanical ingredient powders and extracts (Korean Red Ginseng, Fjord Rhodiola, Red Sage, and others in development) to nutraceutical and cosmeceutical manufacturers. Ingredients are supplied with certifications including DNA identification, vegan, halal, and kosher, along with comprehensive quality analyses. The company operates a co-development model where it partners with clients to develop exclusive botanical ingredients.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractB2B ingredient sales — no public pricing; quote-based

Go-to-market motion1 record

Distribution channels2 records

Marketing channels7 records

BOTALYS product offering

Product offering

Core offering

BOTALYS develops, cultivates, and supplies ultra-pure, standardized premium botanical ingredient powders and extracts — including Korean Ginseng (Panax ginseng), Fjord Rhodiola (Rhodiola rosea), Red & Black Ginseng variants, and an emerging cosmetic active ingredients portfolio — for nutraceutical and cosmeceutical manufacturers. Production relies on its proprietary Biomimetic Indoor Farming vertical-farm technology, which replicates wild botanical habitats to deliver batch-to-batch standardized bioactive profiles equivalent to wild-harvested specimens, with full traceability from seed to ingredient and certifications covering DNA identification, vegan, halal, and kosher compliance. The company also operates a co-development platform enabling the development of exclusive, proprietary botanical ingredients with industry partners from feasibility through industrial scale-up.

Product overview

BOTALYS is a Belgian supplier and developer of premium botanical ingredients for the nutraceutical and cosmeceutical industries. The company operates a proprietary Biomimetic Indoor Farming platform that enables the precise control of plant growth conditions to produce consistent, high-quality botanicals equivalent to wild-harvested plants. Core products include Korean Ginseng (Panax ginseng) for mental stamina and Fjord Rhodiola (Rhodiola rosea) for adaptogenic benefits, alongside processed variants (Red & Black Ginseng). The company also offers a New Plant Development Platform for co-development partnerships to create exclusive botanical ingredients, with emerging cosmetic active ingredients in development. All ingredients are produced in Belgium using vertically integrated seed-to-ingredient processes.

Differentiator

Problem solved

Functional benefit

Products and services

  • Korean Ginseng (Panax ginseng) Premium botanical ingredient developed using BOTALYS' Biomimetic Indoor Farming technology, specifically formulated to promote mental stamina with clinically demonstrated efficacy against factors of mental load including focus, stress, and memory. Contains 10% rare ginsenosides (Rg3, Rg5, Rk1). For nutraceutical manufacturers.
  • Fjord Rhodiola (Rhodiola rosea) Unique Nordic Rhodiola rosea cultivar developed over 4 years of R&D, producing a potent European Rhodiola with a molecular profile equivalent to a 15-year-old wild Nordic specimen. Known for boosting physical and mental stamina. For nutraceutical and adaptogenic supplement manufacturers.
  • Red & Black Ginseng Processed ginseng products derived from BOTALYS' Korean Ginseng, including steam-cooked red ginseng and multi-cycle black ginseng, with enhanced bioactive ginsenoside profiles for various health applications. For nutraceutical manufacturers.
  • Cosmetic Active Ingredients Dedicated portfolio of botanical ingredients being developed for cosmetic applications, targeting the cosmeceutical market. Includes Sichuan Red Sage (Salvia miltiorrhiza) and other actives in development for skincare and personal care formulations. For cosmetic and personal care manufacturers.
  • New Plant Development Platform Co-development platform enabling the development of rare, high-performance botanical ingredients from feasibility to industrial scale through exclusive partnerships with industry leaders. Covers technical specifications, non-technical validation, rare plant sourcing, vitroplant production, cultivar selection, process optimization, and industrial scale-up. For enterprise partners in nutraceuticals, cosmeceuticals, and consumer health.

Quantifiable outcome

  • 74% memory capacity recovery in aged mice supplemented with BOTALYS Red Ginseng vs. young mice in Y-maze test (50 mg/kg/day, 8 days)
  • +6 more outcomes

Companies that use BOTALYS

Customer profile

Named customers9 records

Segments4 records

Ideal customer profiles3 records

BOTALYS technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

BOTALYS partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core.

  • HaleoncoreStrategic or Co-development Partner · 16 October 2025Strategic collaboration announced October 16, 2025 to develop innovative botanical ingredients using BOTALYS' indoor cultivation platform and Haleon's consumer healthcare portfolio. Partnership focuses on scientific and regulatory standards, sustainability, and advancing plant-based health solutions through multiple research and development phases.
  • L'Oréal & BrightseedcoreStrategic or Co-development Partner · 1 January 2024Partnership launched in 2024 with L'Oréal and Brightseed (AI-powered plant compound exploration company) as part of L'Oréal's Green Sciences incubator and R&I Exploration Trailblazer program. The collaboration leverages AI to explore plant compounds for cosmetic applications using BOTALYS' botanical platform.
  • SeppiccoreStrategic or Co-development Partner · 1 January 2023Co-development and distribution partnership launched in 2023. Seppic and BOTALYS signed a partnership for co-development and distribution of botanical ingredients, combining Seppic's formulation expertise and distribution network with BOTALYS' cultivation technology.

Scale indicators8 records

Recent moves9 records

Expansion highlights6 records

BOTALYS competitors and assessment

Company assessment

Direct peers

  • Indena: Italian-headquartered developer and manufacturer of standardized botanical extracts for the pharmaceutical, nutraceutical, and cosmeceutical industries. Directly comparable to BOTALYS in target customers (premium B2B ingredient buyers), botanical standardization expertise, and clinical efficacy focus.
  • Sabinsa: US-based manufacturer of standardized botanical extracts and nutraceutical ingredients with a broad branded SKU portfolio. Highly comparable to BOTALYS as a science-driven, vertically integrated botanical ingredient supplier serving nutraceutical and personal care brands globally.
  • Euromed: Spanish producer of standardized botanical and fruit extracts for nutraceutical and pharmaceutical applications. Comparable to BOTALYS in standardized extract positioning, B2B sales to health brands, and emphasis on clinical-grade quality documentation.
  • OmniActive Health Technologies: Supplier of scientifically validated, naturally sourced ingredients for dietary supplements and functional foods. Comparable to BOTALYS in premium, evidence-led botanical ingredient positioning for global nutraceutical brands.
  • Linnea: Swiss-based manufacturer of high-purity botanical extracts and active pharmaceutical ingredients from medicinal plants. Comparable to BOTALYS in vertically integrated, GMP-grade botanical manufacturing for pharma-adjacent and nutraceutical buyers.

Broad incumbents

  • Naturex (Givaudan): Naturex, now part of Givaudan, is one of the largest global suppliers of plant-based extracts for food, nutraceutical, and cosmetic applications. A broad incumbent offering overlapping standardized botanical capabilities at much greater scale than BOTALYS, including conventional and some cultivated sourcing.
  • Kemin Industries: Global ingredient manufacturer serving human/animal nutrition, food, and personal care with botanical extracts and specialty ingredients. Broader portfolio than BOTALYS but overlaps in standardized plant-based actives for nutraceutical and cosmetic applications.
  • Kerry Group: Global taste and nutrition company supplying functional ingredients, botanical extracts, and nutraceutical solutions to food, beverage, and supplement manufacturers. Broader incumbent with significant overlap in botanical ingredient supply to large CPG customers.

Emerging players

  • Pharmactive Biotech Products: Spanish specialist in premium, sustainably sourced botanical extracts for nutraceutical and functional food markets. Comparable to BOTALYS in B2B premium botanical positioning, clinical substantiation, and focus on unique, differentiated plant actives.
  • ActivInside: French developer of clinically supported, plant-based active ingredients for the nutraceutical and dermo-cosmetic markets. Closely comparable to BOTALYS in premium B2B botanical actives, clinical efficacy positioning, and focus on cosmeceutical channels.

Market position

Strengths1 record

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

BOTALYS social profiles

Digital presence

BOTALYS compliance and trust

Trust signal

Compliance7 records

BOTALYS financial estimates

Financial estimate

Revenue estimate

Valuation estimate

BOTALYS leadership team

Management profile

Number of profiles

Profiles4 records

BOTALYS subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

BOTALYS funding detail

Funding detail

Funding overview

Funding rounds11 records

Investors7 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

BOTALYS M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BOTALYS

What does BOTALYS do?

BOTALYS develops, cultivates, and supplies ultra-pure, standardized premium botanical ingredient powders and extracts — including Korean Ginseng (Panax ginseng), Fjord Rhodiola (Rhodiola rosea), Red & Black Ginseng variants, and an emerging cosmetic active ingredients portfolio — for nutraceutical and cosmeceutical manufacturers. Production relies on its proprietary Biomimetic Indoor Farming vertical-farm technology, which replicates wild botanical habitats to deliver batch-to-batch standardized bioactive profiles equivalent to wild-harvested specimens, with full traceability from seed to ingredient and certifications covering DNA identification, vegan, halal, and kosher compliance. The company also operates a co-development platform enabling the development of exclusive, proprietary botanical ingredients with industry partners from feasibility through industrial scale-up.

Is BOTALYS a public or private company?

BOTALYS is a private company. It is classified as venture growth investor backed and is currently operating.

When was BOTALYS founded?

BOTALYS was founded in 2011. It employs 11 to 50 people.

Where is BOTALYS based?

BOTALYS is headquartered in Ghislenghien, Belgium, in the Europe region.

How does BOTALYS make money?

One revenue line is on record: premium Botanical Ingredients — B2B Ingredient Sales.

Who are BOTALYS's main competitors?

Direct peers on record are Indena, Sabinsa, Euromed, OmniActive Health Technologies and Linnea. Broad incumbents are Naturex (Givaudan), Kemin Industries and Kerry Group. Emerging players are Pharmactive Biotech Products and ActivInside.

Does BOTALYS have an API?

No public API is recorded for BOTALYS.

What industry is BOTALYS in?

BOTALYS's product category is Nutraceutical & Cosmeceutical Botanical Ingredients. Its primary akta.pro industry code is AFAJAKAD, Botanical & Herbal Extracts (Adaptogens, Polyphenols, Essential Oils, Standardized Extracts), with a secondary code of AFAGAHAC, Greenhouse Herb & Microgreens Production (Culinary Herbs, Microgreens). Its NAICS code is 325411 and its SIC code is 2833.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Cosmetics BusinessSeppic and Botalys team up to create cosmetic ingredients from vertical farmingSeppic, a subsidiary of Air Liquide Healthcare, signed a research partnership with Belgian start-up Botalys to co-create natural cosmetic ingredients. The collaboration will use Botalys's soil-less vertical farming to produce high-purity botanical ingredients for cosmetic and healthcare manufacturers, avoiding intensive cultivation in fragile environments.Eurocosmetics-MagSeppic and Botalys signed a co-development and distribution partnership • EURO COSMETICS MagazineSeppic, a subsidiary of Air Liquide Healthcare, and Botalys, a Belgian start-up specializing in rare medicinal plant cultivation, have signed a co-development and distribution partnership for new cosmetic and health ingredients, with a focus on Botalys' ginseng-based products. Seppic will leverage its international distribution network to expand Botalys' reach to cosmetic and healthcare manufacturers globally. The partnership follows ALIAD's investment in Botalys announced in September, aligning with Air Liquide's strategy to support impact start-ups in the natural ingredients space.LinkedInHaleon and Botalys Announce Strategic Partnership to Advance Innovation in Botanical IngredientsHaleon and Botalys announced a strategic partnership in October 2025 to develop innovative botanical ingredients for consumer healthcare, with the project having officially kicked off in September 2025. The collaboration leverages Botalys' proprietary indoor cultivation platform and metabolomic expertise across multiple R&D phases, from cultivar optimisation to pilot-scale production. Both companies aim to deliver a fully characterised botanical solution meeting benchmarks in efficacy, quality, traceability, and sustainability for Haleon's portfolio of trusted brands.iGrow NewsBotalys Banks a USD 6.5M Funding Round Led by ALIADBotalys has secured a USD 6.5 million funding round led by ALIAD, with participation from Yield Lab Europe and existing investors. The capital will be used to accelerate international expansion into American and Asian markets, expand R&D capabilities in Ghislenghien, and facilitate collaboration with Air Liquide subsidiary Seppic. This investment precedes a follow-up funding round of up to USD 7.9 million aimed at supporting the company's growth in precision farming for medicinal plants.GlobeNewswireBOTALYS Adopts Asian Ginseng through ABC’s Adopt-an-Herb ProgramBOTALYS adopted Asian ginseng through ABC's Adopt-an-Herb program, supporting the HerbMedPro database. The company produces HRG80, a hydroponically grown ginseng powder with 12% total ginsenosides, and plans to increase production from 500 kg in 2018 to 2.2 metric tons by end of 2019.